Preterm labor

American Family Physician

Volumn 81, Issue 4, 2010, Pages 477-484

  Sayres Jr , William G ^a  

^a CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; CALCIUM CHANNEL BLOCKING AGENT; CEFAZOLIN; CLINDAMYCIN; CORTICOSTEROID; DEXAMETHASONE; ERYTHROMYCIN; FIBRONECTIN; HEXANOIC ACID; HYDROXYPROGESTERONE; INDOMETACIN; MAGNESIUM SULFATE; METRONIDAZOLE; NIFEDIPINE; PENICILLIN G; PROGESTERONE; TERBUTALINE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIDIURESIS; BIRTH RATE; BRAIN HEMORRHAGE; CERVICAL LENGTH MEASUREMENT; CHLAMYDIASIS; CHORIOAMNIONITIS; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; DEMINERALIZATION; DIAGNOSTIC TEST; DIPLOPIA; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG TOLERABILITY; ENVIRONMENTAL FACTOR; FETUS ECHOGRAPHY; FEVER; FLUSHING; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HALLUCINATION; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HEARTBURN; HEREDITY; HIGH RISK PATIENT; HORMONAL THERAPY; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOKALEMIA; HYPOTENSION; INCIDENCE; INFANT MORTALITY; KIDNEY DISEASE; LETHARGY; LOADING DRUG DOSE; LUNG EDEMA; MAINTENANCE THERAPY; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; NAUSEA; NECROTIZING ENTEROCOLITIS; NERVOUSNESS; NEWBORN MORBIDITY; NEWBORN MORTALITY; OLIGOHYDRAMNIOS; PATHOGENESIS; PERIODONTAL DISEASE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL CARE; PULMONARY HYPERTENSION; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; SEPSIS; SIDE EFFECT; SMOKING; SPONTANEOUS PLACENTAL DELIVERY; STREPTOCOCCUS AGALACTIAE; TACHYCARDIA; THYROID DISEASE; TOCOLYSIS; TRANSVAGINAL ECHOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; TREMOR; UNITED STATES; VAGINITIS; VOMITING; XEROSTOMIA;

EID: 77649250562     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Martin JA, Hamilton BE, Sutton PD, et al., for the Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Births: final data for 2005. Natl Vital Stat Rep. 2007;56(6):1-103.
2. Wright VC, Chang J, Jeng G, Macaluso M. Assisted reproductive technology surveillance - United States, 2003. MMWR Surveill Summ. 2006;55(4):1-22.
3. Alexander GR. Prematurity at birth: determinants, consequences, and geographic variation. In: Behrman RE, Butler AS, eds. Preterm Birth: Causes, Consequences, and Prevention. Washington, DC: National Academies Press; 2007:607-608.
4. Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006;195(6):1557-1563.
5. Centers for Disease Control and Prevention. Table 46. Live births, infant deaths, and infant mortality rates by plurality, birthweight, race of mother, and gestational age: United States, 2001 period data. http://www.cdc.gov/nchs/ data/dvs/LINK01WK46.pdf. Accessed May 31, 2007.
6. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84.
7. Smith GC, Pell JP, Dobbie R. Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study [published correction appears in BMJ. 2003;327(7419):851]. BMJ. 2003;327(7410):313-316.
8. Mercer BM, Goldenberg RL, Moawad AH, et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1999;181(5 pt 1):1216-1221.
9. Adams MM, Elam-Evans LD, Wilson HG, Gilbertz DA. Rates of and factors associated with recurrence of preterm delivery. JAMA. 2000; 283(12):1591-1596.
10. Jakobsson M, Gissler M, Sainio S, Paavonen J, Tapper AM. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia [published correction appears in Obstet Gynecol. 2008;112(4):945]. Obstet Gynecol. 2007;109(2 pt 1):309-313.
11. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res. 2004;(6 suppl 2):S125-S140.
12. Andrews WW, Goldenberg RL, Mercer B, et al. The Preterm Prediction Study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2000;183(3):662-668.
13. Offenbacher S, Boggess KA, Murtha AP, et al. Progressive periodontal disease and risk of very preterm delivery [published correction appears in Obstet Gynecol. 2006;107(5):1171]. Obstet Gynecol. 2006;107(1):29-36.
14. Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996;334(9):567-572.
15. Owen J. Evaluation of the cervix by ultrasound for the prediction of preterm birth. Clin Perinatol. 2003;30(4):735-755.
16. Iams JD, Romero R, Creasy RK. Preterm labor and birth. In: Creasy RK, Resnik R, Iams JD, eds. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 6th ed. Philadelphia, Pa.: Saunders/Elsevier; 2009:559.
17. Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2004;(4):CD001055.
18. Smaill F, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2007;(2):CD000490.
19. Michalowicz BS, Hodges JS, DiAngelis AJ, et al., for the OPT Study. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med. 2006;355(18):1885-1894.
20. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007;(1):CD000262.
21. Lamont RF, Duncan SL, Mandal D, Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol. 2003;101(3):516-522.
22. Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet. 2003;361(9362):983-988.
23. Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ. 2004;329(7462):371.
24. Swadpanich U, Lumbiganon P, Prasertcharoensook W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev. 2008; (2):CD006178.
25. U.S. Preventive Services Task Force. Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148(3):214-219.
26. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74(1):14-22.
27. Workowski KA, Berman SM, for the Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006 [published correction appears in MMWR Recomm Rep. 2006;55(36):997]. MMWR Recomm Rep. 2006;55(RR11):1-94.
28. Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2006;194(5):1234-1242.
29. Meis PJ, Klebanoff M, Thom E, et al., for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate [published correction appears in N Engl J Med. 2003;349(13):1299]. N Engl J Med. 2003;348(24):2379-2385.
30. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003; 188(2):419-424.
31. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH, for the Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007;357(5):462-469.
32. Rouse DJ, Caritis SN, Peaceman AM, et al., for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007;357(5):454-461.
33. American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Use of progesterone to reduce preterm birth. Obstet Gynecol. 2003;102(5 pt 1):1115-1116.
34. ACOG Committee on Practice Bulletins; American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor. Obstet Gynecol. 2003;101(5 pt 1): 1039-1047.
35. Iams JD. Prediction and early detection of preterm labor. Obstet Gynecol. 2003;101(2):402-412.
36. Lockwood CJ. Overview of preterm labor and delivery. UpToDate Online. http://www.utdol.com/patients/content/topic.do?topicKey=~IGteIB-WZFbd8-S (subscription required). Accessed February 23, 2009.
37. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol. 2003;101(1):178-193.
38. Bennett SL, Cullen JB, Sherer DM, Woods JR Jr. The ferning and nitrazine tests of amniotic fluid between 12 and 41 weeks gestation. Am J Perinatol. 1993;10(2):101-104.
39. Peaceman AM, Andrews WW, Thorp JM, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol. 1997;177(1):13-18.
40. Lukes AS, Thorp JM Jr, Eucker B, Pahel-Short L. Predictors of positivity for fetal fibronectin in patients with symptoms of preterm labor. Am J Obstet Gynecol. 1997;176(3):639-641.
41. Ramsey PS, Andrews WW. Biochemical predictors of preterm labor: fetal fibronectin and salivary estriol. Clin Perinatol. 2003;30(4):701-733.
42. Gomez R, Romero R, Medina L, et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes [published correction appears in Am J Obstet Gynecol. 2005; 193(1):308-309]. Am J Obstet Gynecol. 2005;192(2):350-359.
43. Tsoi E, Fuchs IB, Rane S, Geerts L, Nicolaides KH. Sonographic measurement of cervical length in threatened preterm labor in singleton pregnancies with intact membranes. Ultrasound Obstet Gynecol. 2005; 25(4):353-356.
44. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;(3):CD004454.
45. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 402: Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2008;111(3):805-807.
46. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1-22.
47. Honest H, Sharma S, Khan KS. Rapid tests for group B streptococcus colonization in laboring women: a systematic review. Pediatrics. 2006;117(4):1055-1066.
48. King J, Flenady V. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 2002;(4): CD000246.
49. Berkman ND, Thorp JM Jr, Lohr KN, et al. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol. 2003;188(6):1648-1659.
50. Towers CV, Bonebrake R, Padilla G, Rumney P. The effect of transport on the rate of severe intraventricular hemorrhage in very low birth weight infants. Obstet Gynecol. 2000;95(2):291-295.
51. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev. 2005;(2): CD001992.
52. Goldenberg RL. The management of preterm labor. Obstet Gynecol. 2002;100(5 pt 1):1020-1037.
53. Di Renzo GC, Roura LC, for the Europeaon Association of Perinatal Medicine-Study Group on Preterm Birth. Guidelines for the management of spontaneous preterm labor. J Perinat Med. 2006;34(5):359-366.
54. Haas DM, Imperiale TF, Kirkpatrick PR, Klein RW, Zollinger TW, Golichowski AM. Tocolytic therapy: a meta-analysis and deision analysis. Obstet Gynecol. 2009;113(3):585-594.
55. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2002;(4):CD001060.
56. Lyell DJ, Pullen K, Campbell L, et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstet Gynecol. 2007;110(1):61-67.
57. King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev. 2003;(1):CD002255.
58. Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2004;(4):CD004352.
59. Phibbs CS, Baker LC, Caughey AB, Danielsen B, Schmitt SK, Phibbs RH. Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants. N Engl J Med. 2007;356(21):2165-2175.
60. Grant A, Glazener CM. Elective caesarean section versus expectant management for delivery of the small baby. Cochrane Database Syst Rev. 2001;(2):CD000078.
61. Romero R, Hsu YC, Athanassiadis AP, et al. Preterm delivery: a risk factor for retained placenta. Am J Obstet Gynecol. 1990;163(3):823-825.
62. ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 348, November 2006: Umbilical cord blood gas and acid-base analysis. Obstet Gynecol. 2006;108(5):1319-1322.
63. Dodd JM, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev. 2006;(1):CD004947.